ArticleJournal of immune based therapies and vaccines2011

Phase IIb randomized trial of adjunct immunotherapy in patients with first-diagnosed tuberculosis, relapsed and multi-drug-resistant (MDR) TB.

Dmitry A Butov et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.